Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

First-in-Class Vepdegestrant Approved in Advanced Breast Cancer

First-in-Class Vepdegestrant Approved in Advanced Breast Cancer
ShareXFacebook

(MedPage Today) -- The FDA approved oral vepdegestrant (Veppanu) for adults with advanced or metastatic estrogen receptor (ER)-positive/HER2-negative breast cancer, the agency announced on Friday. Approval of the first-in-class proteolysis targeting...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement